Remote evaluation of acute ischemic stroke: reliability of National Institutes of Health Stroke Scale via telestroke.

Sam Wang, Sung Bae Lee, Carol Pardue, Davinder Ramsingh, Jennifer L Waller, Hartmut Gross, Fenwick T Nichols, David C Hess, Robert J. Adams

Research output: Contribution to journalArticle

144 Citations (Scopus)

Abstract

BACKGROUND AND PURPOSE: Despite Food and Drug Administration approval of tissue-type plasminogen activator for stroke, obstacles in the US healthcare system prevent its widespread use. The Remote Evaluation for Acute Ischemic Stroke (REACH) program was developed to address these issues in rural settings. A key component of stroke assessment in the REACH system is the National Institutes of Health Stroke Scale (NIHSS) evaluation. We sought to determine whether, using the REACH system, NIHSS values of bedside and remote evaluators would correspond. METHODS: Twenty patients were recruited. On obtaining consent, a neurologist performed a bedside NIHSS evaluation on each patient. Within 1 hour, using any broadband-connected workstation-either office or home personal computer and a landline phone to speak with the patient-a second neurologist remotely evaluated the patient through the REACH system. Paired t tests and Pearson correlation coefficients were used to examine NIHSS reliability performed bedside and remotely. RESULTS: NIHSS ranged from 1 to 24. Correlations between bedside and remote locations (r=0.9552, P=0.0001) were very strong, and t tests indicate that the means were not different. CONCLUSIONS: The NIHSS can be reliably performed over the REACH system. This supports our endeavor to bring stroke expertise to rural community hospitals.

Original languageEnglish (US)
JournalStroke; a journal of cerebral circulation
Volume34
Issue number10
StatePublished - Jan 1 2003

Fingerprint

National Institutes of Health (U.S.)
Stroke
Drug Approval
Rural Hospitals
Community Hospital
Microcomputers
Tissue Plasminogen Activator
Rural Population
United States Food and Drug Administration
Delivery of Health Care

ASJC Scopus subject areas

  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine
  • Advanced and Specialized Nursing

Cite this

Remote evaluation of acute ischemic stroke : reliability of National Institutes of Health Stroke Scale via telestroke. / Wang, Sam; Lee, Sung Bae; Pardue, Carol; Ramsingh, Davinder; Waller, Jennifer L; Gross, Hartmut; Nichols, Fenwick T; Hess, David C; Adams, Robert J.

In: Stroke; a journal of cerebral circulation, Vol. 34, No. 10, 01.01.2003.

Research output: Contribution to journalArticle

@article{3749bbe659194e8db31498443be4d2ab,
title = "Remote evaluation of acute ischemic stroke: reliability of National Institutes of Health Stroke Scale via telestroke.",
abstract = "BACKGROUND AND PURPOSE: Despite Food and Drug Administration approval of tissue-type plasminogen activator for stroke, obstacles in the US healthcare system prevent its widespread use. The Remote Evaluation for Acute Ischemic Stroke (REACH) program was developed to address these issues in rural settings. A key component of stroke assessment in the REACH system is the National Institutes of Health Stroke Scale (NIHSS) evaluation. We sought to determine whether, using the REACH system, NIHSS values of bedside and remote evaluators would correspond. METHODS: Twenty patients were recruited. On obtaining consent, a neurologist performed a bedside NIHSS evaluation on each patient. Within 1 hour, using any broadband-connected workstation-either office or home personal computer and a landline phone to speak with the patient-a second neurologist remotely evaluated the patient through the REACH system. Paired t tests and Pearson correlation coefficients were used to examine NIHSS reliability performed bedside and remotely. RESULTS: NIHSS ranged from 1 to 24. Correlations between bedside and remote locations (r=0.9552, P=0.0001) were very strong, and t tests indicate that the means were not different. CONCLUSIONS: The NIHSS can be reliably performed over the REACH system. This supports our endeavor to bring stroke expertise to rural community hospitals.",
author = "Sam Wang and Lee, {Sung Bae} and Carol Pardue and Davinder Ramsingh and Waller, {Jennifer L} and Hartmut Gross and Nichols, {Fenwick T} and Hess, {David C} and Adams, {Robert J.}",
year = "2003",
month = "1",
day = "1",
language = "English (US)",
volume = "34",
journal = "Stroke",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - Remote evaluation of acute ischemic stroke

T2 - reliability of National Institutes of Health Stroke Scale via telestroke.

AU - Wang, Sam

AU - Lee, Sung Bae

AU - Pardue, Carol

AU - Ramsingh, Davinder

AU - Waller, Jennifer L

AU - Gross, Hartmut

AU - Nichols, Fenwick T

AU - Hess, David C

AU - Adams, Robert J.

PY - 2003/1/1

Y1 - 2003/1/1

N2 - BACKGROUND AND PURPOSE: Despite Food and Drug Administration approval of tissue-type plasminogen activator for stroke, obstacles in the US healthcare system prevent its widespread use. The Remote Evaluation for Acute Ischemic Stroke (REACH) program was developed to address these issues in rural settings. A key component of stroke assessment in the REACH system is the National Institutes of Health Stroke Scale (NIHSS) evaluation. We sought to determine whether, using the REACH system, NIHSS values of bedside and remote evaluators would correspond. METHODS: Twenty patients were recruited. On obtaining consent, a neurologist performed a bedside NIHSS evaluation on each patient. Within 1 hour, using any broadband-connected workstation-either office or home personal computer and a landline phone to speak with the patient-a second neurologist remotely evaluated the patient through the REACH system. Paired t tests and Pearson correlation coefficients were used to examine NIHSS reliability performed bedside and remotely. RESULTS: NIHSS ranged from 1 to 24. Correlations between bedside and remote locations (r=0.9552, P=0.0001) were very strong, and t tests indicate that the means were not different. CONCLUSIONS: The NIHSS can be reliably performed over the REACH system. This supports our endeavor to bring stroke expertise to rural community hospitals.

AB - BACKGROUND AND PURPOSE: Despite Food and Drug Administration approval of tissue-type plasminogen activator for stroke, obstacles in the US healthcare system prevent its widespread use. The Remote Evaluation for Acute Ischemic Stroke (REACH) program was developed to address these issues in rural settings. A key component of stroke assessment in the REACH system is the National Institutes of Health Stroke Scale (NIHSS) evaluation. We sought to determine whether, using the REACH system, NIHSS values of bedside and remote evaluators would correspond. METHODS: Twenty patients were recruited. On obtaining consent, a neurologist performed a bedside NIHSS evaluation on each patient. Within 1 hour, using any broadband-connected workstation-either office or home personal computer and a landline phone to speak with the patient-a second neurologist remotely evaluated the patient through the REACH system. Paired t tests and Pearson correlation coefficients were used to examine NIHSS reliability performed bedside and remotely. RESULTS: NIHSS ranged from 1 to 24. Correlations between bedside and remote locations (r=0.9552, P=0.0001) were very strong, and t tests indicate that the means were not different. CONCLUSIONS: The NIHSS can be reliably performed over the REACH system. This supports our endeavor to bring stroke expertise to rural community hospitals.

UR - http://www.scopus.com/inward/record.url?scp=0242348774&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242348774&partnerID=8YFLogxK

M3 - Article

C2 - 14500929

AN - SCOPUS:0242348774

VL - 34

JO - Stroke

JF - Stroke

SN - 0039-2499

IS - 10

ER -